These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response. van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717 [TBL] [Abstract][Full Text] [Related]
9. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Mitchell SA; Bansi DS; Hunt N; Von Bergmann K; Fleming KA; Chapman RW Gastroenterology; 2001 Oct; 121(4):900-7. PubMed ID: 11606503 [TBL] [Abstract][Full Text] [Related]
10. Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. Lindström L; Hultcrantz R; Boberg KM; Friis-Liby I; Bergquist A Clin Gastroenterol Hepatol; 2013 Jul; 11(7):841-6. PubMed ID: 23353641 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study. Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305 [TBL] [Abstract][Full Text] [Related]
12. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value. de Vries EM; Wang J; Leeflang MM; Boonstra K; Weersma RK; Beuers UH; Geskus RB; Ponsioen CY Liver Int; 2016 Dec; 36(12):1867-1875. PubMed ID: 26945698 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. Gilger MA; Gann ME; Opekun AR; Gleason WA J Pediatr Gastroenterol Nutr; 2000 Aug; 31(2):136-41. PubMed ID: 10941964 [TBL] [Abstract][Full Text] [Related]
15. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children. Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864 [TBL] [Abstract][Full Text] [Related]
16. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study. Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. Chandrakumar A; Loeppky R; Deneau M; El-Matary W J Pediatr; 2019 Dec; 215():144-151.e3. PubMed ID: 31500861 [TBL] [Abstract][Full Text] [Related]
18. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Färkkilä M; Karvonen AL; Nurmi H; Nuutinen H; Taavitsainen M; Pikkarainen P; Kärkkäinen P Hepatology; 2004 Dec; 40(6):1379-86. PubMed ID: 15565569 [TBL] [Abstract][Full Text] [Related]